The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review

Multiple Sclerosis Journal

Volumn 21, Issue 3, 2015, Pages 305-317

  Marrie, Ruth Ann ^a   Reingold, Stephen ^a   Cohen, Jeffrey ^b   Stuve, Olaf ^c   Trojano, Maria ^d   Sorensen, Per Soelberg ^e   Cutter, Gary ^f   Reider, Nadia ^g  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Scientific and Clinical Review Associates LLC   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d University of Texas Southwestern   (United States)

^e UNIVERSITY OF BARI   (Italy)

^f International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

anxiety; bipolar disorder; comorbidity; depression; incidence; Multiple sclerosis; prevalence; psychosis; systematic review

Indexed keywords

ALCOHOL ABUSE; ANXIETY DISORDER; ASIA; AUSTRALIA; BIPOLAR DISORDER; COMORBIDITY; DEPRESSION; DRUG ABUSE; EUROPE; HUMAN; INCIDENCE; INFORMATION RETRIEVAL; MEDICAL RECORD REVIEW; MENTAL DISEASE; MULTIPLE SCLEROSIS; NORTH AMERICA; PERSONALITY DISORDER; PREVALENCE; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SELF REPORT; STRUCTURED INTERVIEW; SUBSTANCE ABUSE; SYSTEMATIC REVIEW; ANXIETY; POPULATION RESEARCH; MENTAL DISORDERS;

COMORBIDITY; HUMANS; INCIDENCE; MENTAL DISORDERS; MULTIPLE SCLEROSIS; PREVALENCE;

EID: 84924803714     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458514564487     Document Type: Review

References (138)

1. Marrie RA, Horwitz R, Cutter G, et al. Cumulative impact of comorbidity on quality of life in MS. Acta Neurol Scand. 2012 ; 125: 180-186
2. Mohr DC, Goodkin DE, Likosky W, et al. Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Arch Neurol. 1997 ; 54: 531-533
3. Marrie RA, Fisk JD, Yu BN, et al. Mental comorbidity and multiple sclerosis: Validating administrative data to support population-based surveillance. BMC Neurol. 2013 ; 13: 16
4. Rodgers J, Bland R. Psychiatric manifestations of multiple sclerosis: A review. Can J Psychiatry. 1996 ; 41: 441-445
5. Patten SB, Svenson LW, Metz LM. Psychotic disorders in MS: Population-based evidence of an association. Neurology. 2005 ; 65: 1123-1125
6. Marrie R, Reider N, Cohen J, et al. A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview..:
7. Evans C, Beland S, Kulaga S, et al. Incidence and prevalence of multiple sclerosis in the Americas: A systematic review. Neuroepidemiology. 2013 ; 40: 195-210
8. Neyeloff J, Fuchs S, Moreira L. Meta-analyses and Forest plots using a Microsoft Excel spreadsheet: Step-by-step guide focusing on descriptive data analysis. BMC Res Notes. 2012 ; 5: 52
9. Cox DR. The continuity correction. Biometrika. 1970 ; 57: 217-219
10. Brichetto G, Uccelli MM, Mancardi GL, et al. Symptomatic medication use in multiple sclerosis. Mult Scler. 2003 ; 9: 458-460
11. Buchanan RJ, Schiffer R, Stuifbergen A, et al. Demographic and disease characteristics of people with multiple sclerosis living in urban and rural areas. Int J MS Care. 2006 ; 8: 89-98
12. Buchanan RJ, Wang S, Tai-Seale M, et al. Analyses of nursing home residents with multiple sclerosis and depression using the minimum data set. Mult Scler. 2003 ; 9: 171-188
13. Buchanan RJ, Zuniga MA, Carrillo-Zuniga G, et al. A pilot study of Latinos with multiple sclerosis: Demographic, disease, mental health, and psychosocial characteristics. J Soc Work Disabil Rehabil. 2011 ; 10: 211-231
14. Burns MN, Nawacki E, Siddique J, et al. Prospective examination of anxiety and depression before and during confirmed and pseudoexacerbations in patients with multiple sclerosis. Psychosom Med. 2013 ; 75: 76-82
15. Carta MG, Moro MF, Lorefice L, et al. The risk of bipolar disorders in multiple sclerosis. J Affect Disord. 2014 ; 155: 255-260
16. Demakis GJ, Buchanan R, Dewald L. A longitudinal study of cognition in nursing home residents with multiple sclerosis. Disabil Rehabil. 2009 ; 31: 1734-1741
17. Espinola-Nadurille M, Colin-Piana R, Ramirez-Bermudez J, et al. Mental disorders in Mexican patients with multiple sclerosis. J Neuropsychiatry Clin Neurosci. 2010 ; 22: 63-69
18. Feinstein A. An examination of suicidal intent in patients with multiple sclerosis. Neurology. 2002 ; 59: 674-678
19. Feinstein A, O'Connor P, Feinstein K. Multiple sclerosis, interferon beta-1b and depression. A prospective investigation. J Neurol. 2002 ; 249: 815-820
20. Ferrando SJ, Samton J, Mor N, et al. Patient Health Questionnaire-9 to screen for depression in outpatients with multiple sclerosis. Int J MS Care. 2007 ; 9: 99-103
21. Fisk J, Morehouse SA, Brown MG, et al. Hospital-based psychiatric service utilization and morbidity in multiple sclerosis. Can J Neurol Sci. 1998 ; 25: 230-235
22. Forbes A, While A, Mathes L, et al. Health problems and health-related quality of life in people with multiple sclerosis. Clin Rehabil. 2006 ; 20: 67-78
23. Füvesi J, Bencsik K, Losonczi E, et al. Factors influencing the health-related quality of life in Hungarian multiple sclerosis patients. J Neurol Sci. 2010 ; 293: 59-64
24. Galeazzi G, Ferrari S, Giaroli G, et al. Psychiatric disorders and depression in multiple sclerosis outpatients: Impact of disability and interferon beta therapy. Neurol Sci. 2005 ; 26: 255-262
25. Goodin DS. Survey of multiple sclerosis in northern California. Northern California MS Study Group. Mult Scler. 1999 ; 5: 78-88
26. Goretti B, Ghezzi A, Portaccio E, et al. Psychosocial issue in children and adolescents with multiple sclerosis. Neurol Sci. 2010 ; 31: 467-470
27. Harel Y, Barak Y, Achiron A. Dysregulation of affect in multiple sclerosis: New phenomenological approach. Psychiatry Clin Neurosci. 2007 ; 61: 94-98
28. Holper L, Coenen M, Weise A, et al. Characterization of functioning in multiple sclerosis using the ICF. J Neurol. 2010 ; 257: 103-113
29. Hopman WM, Coo H, Edgar CM, et al. Factors associated with health-related quality of life in multiple sclerosis. Can J Neurol Sci. 2007 ; 34: 160-166
30. Horton M, Rudick RA, Hara-Cleaver C, et al. Validation of a self-report comorbidity questionnaire for multiple sclerosis. Neuroepidemiology. 2010 ; 35: 83-90
31. Janardhan V, Bakshi R. Quality of life in patients with multiple sclerosis: The impact of fatigue and depression. J Neurol Sci. 2002 ; 205: 51-58
32. Joffe RT, Lippert GP, Gray TA, et al. Mood disorder and multiple sclerosis. Arch Neurol. 1987 ; 44: 376-378
33. Kang JH, Chen YH, Lin HC. Comorbidities amongst patients with multiple sclerosis: A population-based controlled study. Eur J Neurol. 2010 ; 17: 1215-1219
34. Lehan T, Arango-Lasprilla JC, Macias MÁ, et al. Distress associated with patients' symptoms and depression in a sample of Mexican caregivers of individuals with MS. Rehabil Psychol. 2012 ; 57: 301-307
35. Leonavicius R, Adomaitiene A. Impact of depression on multiple sclerosis patients. Cent Eur J Med. 2012 ; 7: 685-690
36. Leonavicius R, Adomaitiene A, Leskauskas D. The relationships between depression and life activities and well-being of multiple sclerosis patients. Cent Eur J Med. 2011 ; 6: 652-661
37. Levinthal DJ, Rahman A, Nusrat S, et al. Adding to the burden: Gastrointestinal symptoms and syndromes in multiple sclerosis. Mult Scler Int. 2013 ; 2013: 319201
38. Marrie RA, Horwitz RI, Cutter G, et al. The burden of mental comorbidity in multiple sclerosis: Frequent, underdiagnosed, and under-treated. Mult Scler. 2009 ; 15: 385-392
39. Marrie RA, Horwitz RI, Cutter G, et al. Association between comorbidity and clinical characteristics of MS. Acta Neurol Scand. 2011 ; 124: 135-141
40. Marrie RA, Yu BN, Leung S, et al. The incidence and prevalence of thyroid disease do not differ in the multiple sclerosis and general populations: A validation study using administrative data. Neuroepidemiology. 2012 ; 39: 135-142
41. McGuigan C, Hutchinson M. Unrecognised symptoms of depression in a community-based population with multiple sclerosis. J Neurol. 2006 ; 253: 219-223
42. Mohr DC, Hart SL, Julian L, et al. Screening for depression among patients with multiple sclerosis: Two questions may be enough. Mult Scler. 2007 ; 13: 215-219
43. Nuyen J, Schellevisa FG, Satarianob WA, et al. Comorbidity was associated with neurologic and psychiatric diseases: A general practice-based controlled study. J Clin Epidemiol. 2006 ; 59: 1274-1284
44. Pandya R, Metz L, Patten SB. Predictive value of the CES-D in detecting depression among candidates for disease-modifying multiple sclerosis treatment. Psychosomatics. 2005 ; 46: 131-134
45. Patten SB, Berzins S, Metz LM. Challenges in screening for depression in multiple sclerosis. Mult Scler. 2010 ; 16: 1406-1411
46. Patten SB, Fridhandler S, Beck CA, et al. Depressive symptoms in a treated multiple sclerosis cohort. Mult Scler. 2003 ; 9: 616-620
47. Patten SB, Metz LM, Reimer MA. Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population. Mult Scler. 2000 ; 6: 115-120
48. Sadovnick AD, Remick RA, Allen J, et al. Depression and multiple sclerosis. Neurology. 1996 ; 46: 628-632
49. Scott TF, Allen D, Price TR, et al. Characterization of major depression symptoms in multiple sclerosis patients. J Neuropsychiatry Clin Neurosci. 1996 ; 8: 318-323
50. Simioni S, Ruffieux C, Bruggimann L, et al. Cognition, mood and fatigue in patients in the early stage of multiple sclerosis. Swiss Med Wkly. 2007 ; 137: 496-501
51. Tarrants M, Oleen-Burkey M, Castelli-Haley J, et al. The impact of comorbid depression on adherence to therapy for multiple sclerosis. Mult Scler Int. 2011 ; 2011: 271321
52. Thielscher C, Thielscher S, Kostev K. The risk of developing depression when suffering from neurological diseases. Ger Med Sci. 2013 ; 11: Doc02
53. Valleroy ML, Kraft GH. Sexual dysfunction in multiple sclerosis. Arch Phys Med Rehabil. 1984 ; 65: 125-128
54. Zabad RK, Patten SB, Metz LM. The association of depression with disease course in multiple sclerosis. Neurology. 2005 ; 64: 359-360
55. Zorzon M, de Masi R, Nasuelli D, et al. Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects. J Neurol. 2001 ; 248: 416-421
56. Beiske AG, Svensson E, Sandanger I, et al. Depression and anxiety amongst multiple sclerosis patients. Eur J Neurol. 2008 ; 15: 239-245
57. Brajkovi L, Bras M, MilunoviV, et al. The connection between coping mechanisms, depression, anxiety and fatigue in multiple sclerosis. Coll Antropol. 2009 ; 33: 135-140
58. da Silva AM, Vilhena E, Lopes A, et al. Depression and anxiety in a Portuguese MS population: Associations with physical disability and severity of disease. J Neurol Sci. 2011 ; 306: 66-70
59. Dahl OP, Stordal E, Lydersen S, et al. Anxiety and depression in multiple sclerosis. A comparative population-based study in Nord-Trøndelag County, Norway. Mult Scler. 2009 ; 15: 1495-1501
60. Espinola-Nadurille M, Colin-Piana R, Ramirez-Bermudez J, et al. Mental disorders in Mexican patients with multiple sclerosis. J Neuropsychiatry Clin Neurosci. 2010 ; 22: 63-69
61. Foroughipour M, Behdani F, Hebrani P, et al. Frequency of obsessive-compulsive disorder in patients with multiple sclerosis: A cross-sectional study. J Res Med Sci. 2012 ; 17: 248-253
62. Garfield AC, Lincoln NB. Factors affecting anxiety in multiple sclerosis. Disabil Rehabil. 2012 ; 34: 2047-2052
63. Gold SM, Schulz H, Mönch A, et al. Cognitive impairment in multiple sclerosis does not affect reliability and validity of self-report health measures. Mult Scler. 2003 ; 9: 404-410
64. Goretti B, Portaccio E, Zipoli V, et al. Coping strategies, psychological variables and their relationship with quality of life in multiple sclerosis. Neurol Sci. 2009 ; 30: 15-20
65. Hakim EA, Bakheit AM, Bryant TN, et al. The social impact of multiple sclerosis - a study of 305 patients and their relatives. Disabil Rehabil. 2000 ; 22: 288-293
66. Janssens AC, van Doorn PA, de Boer JB, et al. Anxiety and depression influence the relation between disability status and quality of life in multiple sclerosis. Mult Scler. 2003 ; 9: 397-403
67. Kehler MD, Hadjistavropoulos HD. Is health anxiety a significant problem for individuals with multiple sclerosis?. J Behav Med. 2009 ; 32: 150-161
68. Korostil M, Feinstein A. Anxiety disorders and their clinical correlates in multiple sclerosis patients. Mult Scler. 2007 ; 13: 67-72
69. Leonavicius R, Adomaitiene A. Anxiety and social activities in multiple sclerosis patients. Cent Eur J Med. 2013 ; 8: 56-61
70. Merlino G, Fratticci L, Lenchig C, et al. Prevalence of 'poor sleep' among patients with multiple sclerosis: An independent predictor of mental and physical status. Sleep Med. 2009 ; 10: 26-34
71. Montel SR, Bungener C. Coping and quality of life in one hundred and thirty five subjects with multiple sclerosis. Mult Scler. 2007 ; 13: 393-401
72. Moreau T, Schmidt N, Joyeux O, et al. Coping strategy and anxiety evolution in multiple sclerosis patients initiating interferon-beta treatment. Eur Neurol. 2009 ; 62: 79-85
73. Nicholl CR, Lincoln NB, Francis VM, et al. Assessment of emotional problems in people with multiple sclerosis. Clin Rehabil. 2001 ; 15: 657-668
74. Poder K, Ghatavi K, Fisk J, et al. Social anxiety in a multiple sclerosis clinic population. Mult Scler. 2009 ; 15: 393-398
75. Porcel J, Río J, Sánchez-Betancourt A, et al. Long-term emotional state of multiple sclerosis patients treated with interferon beta. Mult Scler. 2006 ; 12: 802-807
76. Siepman TA, Janssens AC, de Koning I, et al. The role of disability and depression in cognitive functioning within 2 years after multiple sclerosis diagnosis. J Neurol. 2008 ; 255: 910-916
77. Smith SJ, Young CA. The role of affect on the perception of disability in multiple sclerosis. Clin Rehabil. 2000 ; 14: 50-54
78. Spain LA, Tubridy N, Kilpatrick TJ, et al. Illness perception and health-related quality of life in multiple sclerosis. Acta Neurol Scand. 2007 ; 116: 293-299
79. Till C, Udler E, Ghassemi R, et al. Factors associated with emotional and behavioral outcomes in adolescents with multiple sclerosis. Mult Scler. 2012 ; 18: 1170-1180
80. Wood B, van der Mei I, Ponsonby AL, et al. Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis. Mult Scler. 2013 ; 19: 217-224
81. Eaton WW, Pedersen MG, Nielsen PR, et al. Autoimmune diseases, bipolar disorder, and non-affective psychosis. Bipolar Disord. 2010 ; 12: 638-646
82. Edwards LJ, Constantinescu CS. A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic. Mult Scler. 2004 ; 10: 575-581
83. Bombardier CH, Blake KD, Ehde DM, et al. Alcohol and drug abuse among persons with multiple sclerosis. Mult Scler. 2004 ; 10: 35-40
84. Lindegard B. Diseases associated with multiple sclerosis and epilepsy. Acta Neurol Scand. 1985 ; 71: 267-277
85. Marrie RA, Horwitz R, Cutter G, et al. High frequency of adverse health behaviors in multiple sclerosis. Mult Scler. 2009 ; 15: 105-113
86. Sheu JJ, Lin HC. Association between multiple sclerosis and chronic periodontitis: A population-based pilot study. Eur J Neurol. 2013 ; 20: 1053-1059
87. Turner AP, Hawkins EJ, Haselkorn JK, et al. Alcohol misuse and multiple sclerosis. Arch Phys Med Rehabil. 2009 ; 90: 842-848
88. Fisk JD, Morehouse SA, Brown MG, et al. Hospital-based psychiatric service utilization and morbidity in multiple sclerosis. Can J Neurol Sci. 1998 ; 25: 230-235
89. Fromont A, Binquet C, Rollot F, et al. Comorbidities at multiple sclerosis diagnosis. J Neurol. 2013 ; 260: 2629-2637
90. McCrone P, Heslin M, Knapp M, et al. Multiple sclerosis in the UK: Service use, costs, quality of life and disability. Pharmacoeconomics. 2008 ; 26: 847-860
91. Patten SB, Svenson LW, Metz LM. Descriptive epidemiology of affective disorders in multiple sclerosis. CNS Spectr. 2005 ; 10: 365-371
92. Patten SB, Williams JV, Lavorato DH, et al. Disability in a community population with MS with and without mental disorders. Int J Psychiatry Med. 2012 ; 43: 51-65
93. Alschuler KN, Jensen MP, Ehde DM. The association of depression with pain-related treatment utilization in patients with multiple sclerosis. Pain Med. 2012 ; 13: 1648-1657
94. Amato MP, Ponziani G, Rossi F, et al. Quality of life in multiple sclerosis: The impact of depression, fatigue and disability. Mult Scler. 2001 ; 7: 340-344
95. Avasarala JR, Cross AH, Trinkaus K. Comparative assessment of Yale Single Question and Beck Depression Inventory Scale in screening for depression in multiple sclerosis. Mult Scler. 2003 ; 9: 307-310
96. Bamer AM, Cetin K, Johnson KL, et al. Validation study of prevalence and correlates of depressive symptomatology in multiple sclerosis. Gen Hosp Psychiatry. 2008 ; 30: 311-317
97. Baumstarck-Barrau K, Simeoni MC, Reuter F, et al. Cognitive function and quality of life in multiple sclerosis patients: A cross-sectional study. BMC Neurol. 2011 ; 11: 17
98. Bodini B, Mandarelli G, Tomassini V, et al. Alexithymia in multiple sclerosis: Relationship with fatigue and depression. Acta Neurol Scand. 2008 ; 118: 18-23
99. Brown RF, Valpiani EM, Tennant CC, et al. Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis. Psychol Psychother. 2009 ; 82 (Pt 1). 41-56
100. Cetin K, Johnson KL, Ehde DM, et al. Antidepressant use in multiple sclerosis: Epidemiologic study of a large community sample. Mult Scler. 2007 ; 13: 1046-1053
101. Chwastiak L, Ehde DM, Gibbons LE, et al. Depressive symptoms and severity of illness in multiple sclerosis: Epidemiologic study of a large community sample. Am J Psychiatry. 2002 ; 159: 1862-1868
102. Einarsson U, Gottberg K, Fredrikson S, et al. Multiple sclerosis in Stockholm County. A pilot study exploring the feasibility of assessment of impairment, disability and handicap by home visits. Clin Rehabil. 2003 ; 17: 294-303
103. Ghajarzadeh M, Sahraian MA, Fateh R, et al. Fatigue, depression and sleep disturbances in Iranian patients with multiple sclerosis. Acta Med Iran. 2012 ; 50: 244-249
104. Gottberg K, Einarsson U, Fredrikson S, et al. A population-based study of depressive symptoms in multiple sclerosis in Stockholm county: Association with functioning and sense of coherence. J Neurol Neurosurg Psychiatry. 2007 ; 78: 60-65
105. Isaksson AK, Gunnarsson LG, Ahlström G. The presence and meaning of chronic sorrow in patients with multiple sclerosis. J Clin Nurs. 2007 ; 16: 315-324
106. Johansson S, Ytterberg C, Claesson IM, et al. High concurrent presence of disability in multiple sclerosis. Associations with perceived health. J Neurol. 2007 ; 254: 767-773
107. Johansson S, Ytterberg C, Hillert J, et al. A longitudinal study of variations in and predictors of fatigue in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2008 ; 79: 454-457
108. Jonsson A, Dock J, Ravnborg MH. Quality of life as a measure of rehabilitation outcome in patients with multiple sclerosis. Acta Neurol Scand. 1996 ; 93: 229-235
109. Julian LJ, Vella L, Frankel D, et al. ApoE alleles, depression and positive affect in multiple sclerosis. Mult Scler. 2009 ; 15: 311-315
110. Kargarfard M, Eetemadifar M, Mehrabi M, et al. Fatigue, depression, and health-related quality of life in patients with multiple sclerosis in Isfahan, Iran. Eur J Neurol. 2012 ; 19: 431-437
111. Ketelslegers IA, Catsman-Berrevoets CE, Boon M, et al. Fatigue and depression in children with multiple sclerosis and monophasic variants. Eur J Paediatr Neurol. 2010 ; 14: 320-325
112. Khan F, Pallant J, Brand C. Caregiver strain and factors associated with caregiver self-efficacy and quality of life in a community cohort with multiple sclerosis. Disabil Rehabil. 2007 ; 29: 1241-1250
113. Klevan G, Jacobsen CO, Aarseth JH, et al. Health related quality of life in patients recently diagnosed with multiple sclerosis. Acta Neurol Scand. 2014 ; 129: 21-26
114. Lobentanz IS, Asenbaum S, Vass K, et al. Factors influencing quality of life in multiple sclerosis patients: Disability, depressive mood, fatigue and sleep quality. Acta Neurol Scand. 2004 ; 110: 6-13
115. Lutterotti A, Vedovello M, Reindl M, et al. Olfactory threshold is impaired in early, active multiple sclerosis. Mult Scler. 2011 ; 17: 964-969
116. Maor Y, Olmer L, Mozes B. The relation between objective and subjective impairment in cognitive function among multiple sclerosis patients - the role of depression. Mult Scler. 2001 ; 7: 131-135
117. Mattioli F, Bellomi F, Stampatori C, et al. Depression, disability and cognitive impairment in multiple sclerosis: A cross sectional Italian study. Neurol Sci. 2011 ; 32: 825-832
118. Noy S, Achiron A, Gabbay U, et al. A new approach to affective symptoms in relapsing-remitting multiple sclerosis. Compr Psychiatry. 1995 ; 36: 390-395
119. Patten SB, Lavorato DH, Metz LM. Clinical correlates of CES-D depressive symptom ratings in an MS population. Gen Hosp Psychiatry. 2005 ; 27: 439-445
120. Patti F, Cacopardo M, Palermo F, et al. Health-related quality of life and depression in an Italian sample of multiple sclerosis patients. J Neurol Sci. 2003 ; 211: 55-62
121. Patti F, Pozzilli C, Montanari E, et al. Effects of education level and employment status on HRQoL in early relapsing-remitting multiple sclerosis. Mult Scler. 2007 ; 13: 783-791
122. Pittion-Vouyovitch S, Debouverie M, Guillemin F, et al. Fatigue in multiple sclerosis is related to disability, depression and quality of life. J Neurol Sci. 2006 ; 243: 39-45
123. Romberg A, Ruutiainen J, Puukka P, et al. Fatigue in multiple sclerosis patients during inpatient rehabilitation. Disabil Rehabil. 2008 ; 30: 1480-1485
124. Seyed Saadat SM, Hosseininezhad M, Bakhshayesh B, et al. Prevalence and predictors of depression in Iranian patients with multiple sclerosis: A population-based study. Neurol Sci. 2014 ; 35: 735-740
125. Sollom AC, Kneebone. Treatment of depression in people who have multiple sclerosis. Mult Scler. 2007 ; 13: 632-635
126. Sundgren M, Maurex L, Wahlin A, et al. Cognitive impairment has a strong relation to nonsomatic symptoms of depression in relapsing-remitting multiple sclerosis. Arch Clin Neuropsychol. 2013 ; 28: 144-155
127. Tanriverdi D, Okanli A, Sezgin S, et al. Quality of life in patients with multiple sclerosis in Turkey: Relationship to depression and fatigue. J Neurosci Nurs. 2010 ; 42: 267-273
128. Vogt A, Kappos L, Calabrese P, et al. Working memory training in patients with multiple sclerosis - comparison of two different training schedules. Restor Neurol Neurosci. 2009 ; 27: 225-235
129. Williams RM, Turner AP, Hatzakis M, et al. Prevalence and correlates of depression among veterans with multiple sclerosis. Neurology. 2005 ; 64: 75-80
130. Zettl UK, Bauer-Steinhusen U, Glaser T, et al. Evaluation of an electronic diary for improvement of adherence to interferon beta-1b in patients with multiple sclerosis: Design and baseline results of an observational cohort study. BMC Neurol. 2013 ; 13: 117
131. Ferrari AJ, Charlson FJ, Norman RE, et al. Burden of depressive disorders by country, sex, age, and year: Findings from the Global Burden of Disease Study 2010. PLoS Med. 2013 ; 10: e1001547
132. Baxter AJ, Vos T, Scott KM, et al. The regional distribution of anxiety disorders: Implications for the Global Burden of Disease Study, 2010. Int J Methods Psychiatr Res. 2014 ;:
133. Irwin MR, Miller AH. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun. 2007 ; 21: 374-383
134. Lotrich FE, El-Gabalawy H, Guenther LC, et al. The role of inflammation in the pathophysiology of depression: Different treatments and their effects. J Rheumatol. 2011 ; 88: 48-54
135. Feinstein A. Multiple sclerosis and depression. Mult Scler. 2011 ; 17: 1276-1281
136. Yadav R, Zigmond AS. Temporal lobe lesions and psychosis in multiple sclerosis. BMJ Case Rep. 2010 2010 ;:
137. Minden SL, Orav J, Schildkraut JJ. Hypomanic reactions to ACTH and prednisone treatment for multiple sclerosis. Neurology. 1988 ; 38: 1631-1634
138. Ciriaco M, Ventrice P, Russo G, et al. Corticosteroid-related central nervous system side effects. J Pharmacol Pharmacother. 2013 ; 4: S94 - S98